Methylenetetrahydrofolate reductase polymorphism and risk of colorectal adenomas

Tomomi Marugame, Emiko Tsuji, Hisako Inoue, Sachiko Shinomiya, Chikako Kiyohara, Kazuya Onuma, Hiroaki Hamada, Hiroko Koga, Koichi Handa, Hitomi Hayabuchi, Suminori Kono

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

A homozygous mutation at bp 677 in the gene for the methylenetetrahydrofolate reductase (MTHFR) was previously shown to be associated with a decreased risk of colorectal cancer. We examined the relation between the MTHFR genetic polymorphism and risk of colorectal adenoma in Japanese men using 205 cases of colorectal adenomas and 220 controls of normal total colonoscopy. The homozygous mutation was not measurably associated with colorectal adenomas. The findings corroborate the lack of an association between the MTHFR genotype and colorectal adenomas, but do not deny the possibility that the genotype may be involved in the late stage of colorectal carcinogenesis. Copyright (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)181-186
Number of pages6
JournalCancer Letters
Volume151
Issue number2
DOIs
Publication statusPublished - Apr 14 2000

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Methylenetetrahydrofolate reductase polymorphism and risk of colorectal adenomas'. Together they form a unique fingerprint.

  • Cite this

    Marugame, T., Tsuji, E., Inoue, H., Shinomiya, S., Kiyohara, C., Onuma, K., Hamada, H., Koga, H., Handa, K., Hayabuchi, H., & Kono, S. (2000). Methylenetetrahydrofolate reductase polymorphism and risk of colorectal adenomas. Cancer Letters, 151(2), 181-186. https://doi.org/10.1016/S0304-3835(99)00412-7